Detalhe da pesquisa
1.
When molecular outsmarts morphology: Malignant ossifying fibromyxoid tumors masquerading as osteosarcomas, including a novel CREBZF::PHF1 fusion.
Genes Chromosomes Cancer
; 63(1): e23206, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819540
2.
The Weighted Toxicity Score: Confirmation of a Simple Metric to Communicate Toxicity in Randomized Trials of Systemic Cancer Therapy.
Oncologist
; 29(1): 67-74, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449664
3.
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.
Oncologist
; 28(5): 453-459, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724001
4.
Neoadjuvant Chemotherapy in Retroperitoneal Sarcoma: A National Cohort Study.
Ann Surg Oncol
; 30(11): 6886-6893, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488394
5.
Neoadjuvant chemotherapy in patients undergoing neoadjuvant radiation for trunk and extremity soft tissue sarcoma.
J Surg Oncol
; 128(4): 628-634, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148468
6.
Brightline-1: phase II/III trial of the MDM2-p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS.
Future Oncol
; 19(9): 621-629, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36987836
7.
Ewing sarcoma and related FET family translocation-associated round cell tumors: A century of clinical and scientific progress.
Genes Chromosomes Cancer
; 61(8): 509-517, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443099
8.
Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma.
Cancer Immunol Immunother
; 71(4): 807-818, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34415404
9.
Regorafenib for the Treatment of Sarcoma.
Curr Treat Options Oncol
; 23(11): 1477-1502, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36178573
10.
Sorafenib for Advanced and Refractory Desmoid Tumors.
N Engl J Med
; 379(25): 2417-2428, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575484
11.
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.
Cancer
; 126(1): 98-104, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31536651
12.
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
Oncologist
; 25(11): e1655-e1662, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32701199
13.
Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer.
Future Oncol
; 16(1): 4289-4301, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31778074
14.
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.
Cancer
; 125(24): 4435-4441, 2019 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31503332
15.
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Cancer
; 125(15): 2610-2620, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173362
16.
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.
Cancer
; 125(14): 2445-2454, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31034598
17.
Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.
Br J Cancer
; 120(11): 1026-1032, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31065111
18.
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.
Oncologist
; 24(6): 857-863, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126857
19.
Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas.
Mod Pathol
; 32(12): 1772-1785, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263176
20.
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
BMC Cancer
; 19(1): 593, 2019 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31208434